CAS 1132936-00-5

ABT-072

CAS : 1132936-00-5

ABT-072 is a direct-acting antiviral (DAA) agent, specifically designed as an inhibitor of the hepatitis C virus (HCV) NS5B polymerase. This compound originates from advanced pharmaceutical research and development efforts aimed at targeting viral replication mechanisms. Being an NS5B polymerase inhibitor, ABT-072 functions by interfering with the viral RNA-dependent RNA polymerase. This enzyme plays a critical role in the replication cycle of the hepatitis C virus, facilitating the synthesis of new viral RNA strands. By inhibiting this enzyme, ABT-072 effectively halts viral replication.

Formule : C₂₄H₂₇N₃O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 469.6 g/mol

Ref: 3D-HVB93600

ABT-072

CAS : 1132936-00-5

ABT-072 is a nonnucleoside NS5B polymerase inhibitor and a candidate drug evaluated for treatment of hepatitis C virus.

Formule : C₂₄H₂₇N₃O₅S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 469.55

Ref: TM-T14086